What Is End-of-Life Care for Essential Thrombocythemia or Polycythemia Vera?
By CRYSTAL BAI •
The short answer: Essential thrombocythemia (ET) and polycythemia vera (PV) are usually chronic myeloproliferative neoplasms, but transformation to MF or blast phase AML marks a transition to a potentially life-limiting condition requiring palliative and hospice care.
Understanding ET and PV at End of Life
Essential thrombocythemia (ET) and polycythemia vera (PV) are Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) that typically have long, manageable chronic phases. However, both can transform to more aggressive disease — ET or PV can evolve to myelofibrosis (MF), and MF can further transform to blast-phase AML. These transformations mark critical inflection points requiring reassessment of goals of care.
Transformation and Prognosis
Transformation from ET/PV to post-ET/post-PV myelofibrosis significantly worsens prognosis. Further transformation to blast-phase AML carries a very poor prognosis, particularly in older patients who are not transplant candidates. When transformation occurs, goals-of-care conversations must occur promptly.
Symptom Management in Advanced MPN
Advanced MPN causes severe constitutional symptoms (fatigue, night sweats, weight loss), massive splenomegaly causing pain and early satiety, cytopenias, and potential blast crisis symptoms. Palliative care addresses symptom burden while maintaining quality of life for as long as possible.
The Long-Term MPN Patient
Many ET/PV patients have lived with their diagnosis for 10–20 years before facing end-of-life issues. The psychological shift from "chronic manageable disease" to "approaching end of life" is significant and requires support for both patients and long-term caregivers who may have been managing the condition for decades.
Frequently Asked Questions
When does ET or PV become life-threatening?
ET and PV can transform to myelofibrosis and eventually blast-phase AML — transitions that significantly worsen prognosis and require reassessment of treatment goals.
When should an ET/PV patient consider hospice?
Hospice is appropriate when transformation to blast-phase AML or severe MF has occurred, treatment options are exhausted, and prognosis is six months or less.
What symptoms are managed at end of life with ET/PV?
Key symptoms include constitutional symptoms, massive splenomegaly pain, cytopenias, and blast crisis-related complications.
Can a death doula support a patient with decades of MPN history?
Yes. Death doulas help patients and families navigate the significant psychological shift from chronic disease management to end-of-life care after a long illness journey.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.